Utility of the ART for the LOH syndrome

Utility of the ART for the LOH syndrome - Clinical trial about the utility of the androgen replacement therapy (ART) in late-onset hypogonadism (LOH) syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001946

Enrollment

500

Registered

2011-05-01

Start date

2007-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

late-onset hypogonadism syndrome

Interventions

testosterone drug no treatment

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: PSA < 2.0 ng/ml, Free-T < 11.8 pg/ml

Exclusion criteria

Exclusion criteria: Prostate cancer serious complications

Design outcomes

Primary

Measure	Time frame
The improvement of the subjective symptoms using question paper	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026